|
|
|
N/A
|
2.5M
$0
|
|
Nuveen Cr Strategies Income
|
|
N/A
|
93.2K
$0
|
|
|
|
|
N/A
|
12.8K
$0
|
|
|
|
|
N/A
|
10.3K
$0
|
|
|
|
|
N/A
|
11.2K
$0
|
|
|
|
|
N/A
|
3M
$0
|
|
|
|
|
N/A
|
5M
$0
|
|
|
|
|
N/A
|
200K
$0
|
|
|
|
|
N/A
|
31.6K
$0
|
|
|
|
|
N/A
|
7.93M
$0
|
|
|
|
|
N/A
|
99.5K
$0
|
|
|
|
|
N/A
|
67.9K
$0
|
|
Halozyme Therapeutics Inc
|
|
N/A
|
2.5M
$0
|
|
|
|
|
N/A
|
67K
$0
|
|
|
|
|
N/A
|
35.1K
$0
|
|
|
|
|
N/A
|
26.8M
$0
|
|
|
|
|
N/A
|
63.7K
$0
|
|
Nextera Energy Cap Hldgs Inc
|
|
N/A
|
17.5M
$0
|
|
Hennessy Cap Invt Corp Vii
|
|
N/A
|
284K
$0
|
|
|
|
|
N/A
|
13.7K
$0
|
|
Roman Dbdr Acquisition Corp
|
|
N/A
|
364K
$0
|
|
|
|
|
N/A
|
928
$0
|
|
|
|
|
N/A
|
59.5K
$0
|
|
|
|
|
N/A
|
41.4K
$0
|
|
|
|
|
N/A
|
3.24K
$0
|
|
|
|
|
N/A
|
17.3K
$0
|
|
|
|
|
N/A
|
148K
$0
|
|
Avadel Pharmaceuticals PLC
|
|
N/A
|
422
$0
|
|
|
|
|
N/A
|
70.1K
$0
|
|
|
|
|
N/A
|
32.5K
$0
|
|
|
|
|
N/A
|
75.6K
$0
|
|
|
|
|
N/A
|
10.4K
$0
|
|
|
|
|
N/A
|
34.9K
$0
|
|
|
|
|
N/A
|
46.7K
$0
|
|
|
|
|
N/A
|
863K
$0
|
|
Saba Capital Income & Opport
|
|
N/A
|
23.5K
$0
|
|
|
|
|
N/A
|
57.2K
$0
|
|
|
|
|
N/A
|
3.45K
$0
|
|
|
|
|
N/A
|
44K
$0
|
|
Aardvark Therapeutics Inc
|
|
N/A
|
11.7K
$0
|
|
Concentra Group Holdings Par
|
|
N/A
|
71.6K
$0
|
|
|
|
|
N/A
|
10.7K
$0
|
|
|
|
|
N/A
|
2.33K
$0
|
|
|
|
|
N/A
|
58K
$0
|
|
|
|
|
N/A
|
6.5M
$0
|
|
